Merix Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.65 M
as on 17-12-2024
- Revenue 105.65%
(FY 2023)
- Profit 34.23%
(FY 2023)
- Ebitda 91.31%
(FY 2023)
- Net Worth 21.72%
(FY 2023)
- Total Assets 23.95%
(FY 2023)
About Merix Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.65 M.
Vatipally Reddy, Vatipally Reddy, and Vattipalli Madhavi serve as directors at the Company.
- CIN/LLPIN
U24230TG2006PTC049825
- Company No.
049825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Merix Laboratories Private Limited offer?
Merix Laboratories Private Limited offers a wide range of products and services, including Business Consultant, Management Consultancy, BPO Services, Outsourcing Service.
Who are the key members and board of directors at Merix Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vatipally Reddy  | Director | 13-Apr-2006 | Current |
| Vatipally Reddy | Additional Director | 27-May-2024 | Current |
| Vattipalli Madhavi | Director | 13-Apr-2006 | Current |
Financial Performance of Merix Laboratories.
Merix Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 105.65% increase. The company also saw a substantial improvement in profitability, with a 34.23% increase in profit. The company's net worth Soared by an impressive increase of 21.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merix Laboratories?
Unlock access to Merix Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Merix Hospitality LlpActive 1 year 1 monthVatipally Reddy, Vatipally Reddy and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Dec 2023 | ₹3.65 M | Open |
How Many Employees Work at Merix Laboratories?
Unlock and access historical data on people associated with Merix Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merix Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merix Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
